[Bone scintigraphy in the diagnosis of primary bone tumors (author's transl)].
Bone scintigraphy has improved greatly since the introduction of bone-seeing short-lived radionuclides. The main field of interest is the search for metastases into bone. The uncharacteristic accumulation of radiopharmaceutical agents in different bone lesions makes specific diagnostic evaluations unlikely. With careful selection of cases, however, scintigraphy can also be used in primary bone tumors as a supplementary means of diagnosis as well as having a positive effect on treatment. Clinical examples are presented to demonstrate the range of application of bone scintigraphy.
D001859:Bone Neoplasms / Q000175:diagnosis*; D002812:Chondroma / Q000175:diagnosis; D005350:Fibroma / Q000175:diagnosis; D005461:Fluorine; D005870:Giant Cell Tumors / Q000175:diagnosis; D007719:Knee Joint; D009362:Neoplasm Metastasis; D010017:Osteoma, Osteoid / Q000175:diagnosis; D012516:Osteosarcoma / Q000175:diagnosis; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012512:Sarcoma, Ewing / Q000175:diagnosis; D013585:Synovitis / Q000175:diagnosis; D013667:Technetium
D011868:Radioisotopes; D005461:Fluorine; D013667:Technetium
Knochengeschwülste: Nuklearmedizinische Diagnostik